Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

NCT00447005 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma

Interventions

DRUG: Axitinib (AG-013736)

Sponsor

Pfizer